CD5, CD7, and CD30 expression levels in PTCL were 85%, 50%, and 16%, respectively; in AITL, 96%, 57%, and 32–50%, respectively; in ALCL, 30%, 32–54%, and 93%, respectively [46]. This evidence concerns the gene TNFRSF8 and angioimmunoblastic T-cell lymphoma.